SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-05-014766
Filing Date
2005-03-10
Accepted
2005-03-10 10:18:25
Documents
1
Period of Report
2004-05-27

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION b54017am.html 4/A  
1 MAIN DOCUMENT DESCRIPTION b54017am.xml 4/A 3492
  Complete submission text file 0001209191-05-014766.txt   5403
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Issuer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661
SIC: 2834 Pharmaceutical Preparations

Mailing Address 38 JERMYN STREET LONDON X0 SW1Y 6DN
Business Address 38 JERMYN STREET LONDON X0 SW1Y 6DN 44 20 7534 1508
Abingworth Management LTD (Reporting) CIK: 0001291892 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-50743 | Film No.: 05670947